Lammy refuses to meet Israeli counterpart over Gaza
Shadow Foreign Secretary David Lammy reveals his principled refusal to meet with Israel's top diplomat Eli Cohen, citing concerns over civilian casualties and humanitarian crisis in Gaza.
Shadow Foreign Secretary David Lammy reveals his principled refusal to meet with Israel's top diplomat Eli Cohen, citing concerns over civilian casualties and humanitarian crisis in Gaza.
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Shocking incident raises urgent questions about rugby league's concussion protocols as Storm forward collapses on field following head injury.
The teenage son of NFL legend Eli Manning pays heartfelt homage to his father's football legacy with a creative Halloween costume that's winning hearts across social media.
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Israeli hostage Eli Sharabi's shocking memoir reveals brutal captivity in Hamas tunnels 100ft deep, surrounded by sewage and insects, and his incredible will to survive against all odds.
The NHS strikes landmark agreement with Eli Lilly for Mounjaro, a groundbreaking diabetes medication showing remarkable weight loss results, as Health Secretary Wes Streeting announces ambitious healthcare reforms.
The fictional college football hopeful Chad Powers, portrayed by NFL legend Eli Manning, has an unexpected encounter with the viral 'Hawk Tuah' sensation Hailey Welch in a must-see television moment.
Former NFL quarterback Eli Manning shines in his new Disney+ comedy series 'Chad Powers', delivering unexpected laughs and proving his acting chops in this must-watch football mockumentary.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Financial markets experienced significant volatility as gold hit record highs while pharmaceutical giant Eli Lilly faced pressure over drug pricing concerns. Get the latest analysis on today's market movements.
Hulu confirms the release date for Glen Powell's 'Chad Powers' comedy series, born from a viral ESPN sketch. Discover the story behind the football misfit's journey to the screen.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
The harrowing, hope-filled childhood of author Trent Dalton is now a major Netflix series. Discover the incredible true story of drug lords, a mute magician, and a mother's fight for redemption that inspired a literary phenomenon.
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Disney+ has pulled the plug on the highly anticipated 'Chad Powers' series, starring Glen Powell, in a major strategic U-turn that has stunned the industry and left fans reeling.
Virgin Radio DJ Chris Evans offers a heartfelt update on his 13-year-old son Eli's recovery from a major operation, sharing a rare and touching family photo from the hospital.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.